Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Argenx said Monday it would buy ...

Casey’s reporting examines the use of artificial intelligence by providers and insurers. It is one of the oldest mysteries in medicine: Why do fundamentally healthy people drop dead? Sudden cardiac ...

WASHINGTON — A Food and Drug Administration advisory panel recommended on Friday that compounding pharmacies be allowed to ...

The number of measles cases in the U.S. has surpassed the record-breaking tally for all of 2025, with five more months of ...

A former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech ...

Today, a win for RFK Jr., as an FDA panel narrowly voted in favor of allowing compounding pharmacies to produce certain ...

The Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of research ...

Federal health officials are investigating a new outbreak of the diarrhea-causing parasite. We don’t know where or which ...

Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started ...

In a win for peptide proponents, an FDA advisory panel recommended compounding pharmacies be allowed to make four of the ...

A study of the long-term health impact of the Lahaina wildfires is inspiring a new model for disaster recovery and support.

Unexpected alliances among Republicans and Democrats were on display over a bill meant to rein in ultra-processed foods.